Form 8-K - Current report:
SEC Accession No. 0001401914-19-000109
Filing Date
2019-12-26
Accepted
2019-12-26 16:09:35
Documents
1
Period of Report
2019-12-19
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K dare8-k.htm 8-K 25562
  Complete submission text file 0001401914-19-000109.txt   26891
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

EIN.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36395 | Film No.: 191310676
SIC: 2834 Pharmaceutical Preparations